Top 50 Clinical Trial Platform in Europe

The startup offers a patient recruitment platform that connects clinical researchers with individuals seeking treatment options by providing detailed information on clinical trials, including eligibility criteria and study objectives. This platform addresses the challenge of patient enrollment in clinical studies, facilitating access to potential treatment opportunities for patients and enhancing recruitment efficiency for researchers.

R.grid provides an AI-driven automation platform that integrates trial management processes from pre-trial to trial close, significantly reducing administrative errors and delays. Its products, Inclusive and TrialEngine, streamline patient recruitment and automate complex workflows, cutting trial timelines by months and enhancing overall trial success rates.

myTomorrows is a global platform that connects patients with unmet medical needs to clinical trials and treatments in development, utilizing personalized patient navigation and advanced search technology. The platform addresses the challenge of accessing timely treatment options by providing patients and healthcare professionals with streamlined resources and support for clinical trial enrollment and expanded access programs.

Trialbee offers the Honey Platform, a vendor-agnostic patient recruitment solution that centralizes recruitment activities and provides real-time tracking and reporting. By utilizing data-driven modeling and targeted outreach, Trialbee enhances patient engagement and referral quality while reducing the burden on clinical sites.

OneStudyTeam offers the StudyTeam platform, a cloud-based solution that digitizes clinical trial site workflows to enhance patient recruitment and enrollment efficiency. By providing real-time visibility into recruitment activities, the platform reduces administrative burdens on research sites and enables sponsors to optimize patient enrollment strategies.

OASYS NOW is developing an AI-powered patient recruitment platform that utilizes health data to match individuals with relevant clinical trials, significantly reducing the time required to identify eligible patient cohorts from months to minutes. The GRIP app empowers users to control their health data and receive personalized insights, facilitating faster access to potential treatments.

The startup has developed a proteomics platform that utilizes quantitative and targeted biomarker analysis to provide molecular insights into drug response. This technology accelerates clinical trials across various disease areas, enabling pharmaceutical companies to enhance trial success rates and improve access to therapies.

SubjectWell is a patient recruitment platform that utilizes machine learning to match healthcare-motivated patients with clinical studies across various therapeutic areas, ensuring a diverse and pre-qualified patient pool. By streamlining the connection between sponsors, CROs, and patients, SubjectWell reduces the time to start screening patients from weeks to days, enhancing the efficiency of clinical trials.

iLoF utilizes a cloud-based platform that employs photonics and AI to create a digital library of optical fingerprints for non-invasive patient screening and stratification in clinical trials. This technology reduces screening time by 70% and costs by 40%, while providing a more qualified pool of candidates for drug development.

Biorce develops Jarvis, the first Clinical AI Assistant that utilizes artificial intelligence to streamline clinical trial design, protocol development, and patient recruitment. This technology addresses delays in drug development by providing rapid access to clinical data, enhancing efficiency and reducing costs for researchers and healthcare providers.

Clerkenwell Health is a clinical research organization specializing in psychedelic therapies, utilizing a vetted patient database and experienced investigators to enhance access to psychiatric and central nervous system (CNS) trials. The company addresses the need for effective treatment options in psychiatric conditions by streamlining clinical development processes and improving patient recruitment.

Menken provides eTMF and eISF platforms integrated with MenkenMONITOR, utilizing intelligent automation to enhance the management of clinical trial documentation and oversight. This technology reduces manual workload, minimizes errors, and improves data compliance, accelerating the overall trial process and ensuring timely delivery of life-saving treatments.

The startup operates an independent Site Management Organization that conducts clinical trials by identifying, recruiting, and retaining patients at dedicated research sites. This service enables Contract Research Organizations and pharmaceutical companies to efficiently match patients with appropriate trials across various therapeutic areas.

uMed utilizes the ACCESS Research Platform to automate the clinical studies process by creating consented patient cohorts and integrating electronic health records with real-time clinical outcomes. This approach addresses the challenges of slow patient enrollment and limited access to diverse populations in clinical research, enabling faster and more representative studies.

Acclinate utilizes community engagement and predictive insights to enhance diversity in clinical trials by connecting pharmaceutical companies with underrepresented communities of color. This approach addresses the lack of representation in clinical research, helping to meet FDA diversity requirements while reducing recruitment costs and time.

ConcertAI is an AI-driven platform that utilizes real-world data and advanced analytics to enhance clinical trial design and execution in oncology. The company addresses the inefficiencies in cancer research by providing biopharma partners with actionable insights to accelerate drug development and improve patient outcomes.

Clouds of Care de-risks CNS clinical development by identifying and validating clinically relevant endpoints through multimodal data aggregation and analysis. Their platform connects to a network of Digital Health Technologies to generate scientifically validated insights, improving the probability of success for CNS drug development.

Theremia utilizes an AI-driven platform to enhance drug efficacy and minimize side effects by tailoring treatments to the specific needs of diverse patient demographics. The company improves clinical trial processes, leading to more precise outcomes and faster market access for pharmaceutical products.

Skezi provides a specialized software platform for managing e-cohorts, enabling the collection and analysis of health data directly from patients, caregivers, and healthcare providers. This approach enhances clinical research and patient monitoring by integrating patient-reported outcomes into routine medical evaluations, thereby improving the quality of care.

Akrivia Health utilizes AI-powered natural language processing to analyze the world's largest dataset of de-identified psychiatric records, facilitating real-world evidence generation and clinical trial optimization for mental health and dementia research. By improving patient recruitment and study feasibility, the platform addresses the high costs and lengthy timelines associated with clinical trials in these critical areas.

Whyze Health is a digital platform that connects patients, healthcare providers, payers, and pharmaceutical companies through secure data sharing, enabling collaborative care and improved treatment options. By facilitating direct communication among all stakeholders, the platform enhances patient outcomes and increases access to clinical trials.

The startup offers a drug development platform that utilizes AI-driven asset diligence and valuation to enhance investment decision-making in biopharma. By providing a drug asset marketplace, the platform accelerates drug pipeline development and optimizes return on investment, enabling clients to effectively evaluate and present asset value during strategic planning and deal negotiations.

The startup develops a cloud-based computational chemistry platform that utilizes advanced chemical simulations to streamline the design and testing of chemical and pharmaceutical products. By providing a user-friendly interface and robust security features, the platform accelerates product development while ensuring data integrity.

Empatica develops FDA-cleared wearable devices and a health monitoring platform that continuously collects clinical-quality health data and digital biomarkers from everyday life. This technology enables researchers and clinicians to monitor conditions such as epilepsy and movement disorders, enhancing data collection for clinical trials and real-world health insights.

AARDEX Group provides MEMS AS®, a medication adherence software that utilizes over seventy proprietary algorithms to monitor and analyze medication-taking behaviors in clinical trials. This technology addresses the issue of non-adherence, which affects up to 50% of trial participants, by delivering real-time insights that help researchers identify and support individuals who may struggle with their medication regimens.

The startup develops a cancer data and biomarker discovery platform that integrates disparate cancer data sources and employs machine learning techniques for real-world data analysis. This platform enables secure and instantaneous sharing of patient data for clinical research, significantly reducing the time from discovery to treatment.

Provides a federated data platform for healthcare organizations, enabling the integration and harmonization of structured and unstructured clinical data using NLP and OMOP CDM. This system supports real-world evidence generation and multicenter studies in oncology and cardiology, improving data quality and accelerating research while ensuring compliance with privacy regulations.

The startup develops a lead generation and marketing platform that utilizes proprietary algorithms to aggregate scientific data from online sources, creating a comprehensive database tailored for the life sciences and biopharma sectors. This platform enables pharmaceutical and biotech companies to efficiently identify and connect with external scientists for clinical trial partnerships.

The startup operates an artificial intelligence platform that integrates data across the healthcare ecosystem to enhance treatment options and improve patient outcomes. By democratizing access to clinical trials, the platform enables healthcare providers to deliver more effective services to patients.

Akkure is a digital platform utilizing AI and genomics to enhance clinical trial recruitment for oncology by providing precise patient-trial matching and personalized trial recommendations. The platform ensures GDPR and HIPAA compliance, facilitating secure access and ownership of clinical data while streamlining the enrollment process for patients and healthcare providers.

VCTC operates patient-centric clinical trial sites that utilize streamlined recruitment processes and direct access methods to enhance participation in clinical research. By removing traditional barriers, VCTC accelerates patient enrollment and ensures diverse representation, ultimately delivering high-quality data for faster treatment development.

Stitch provides a patient engagement platform that automates reminders and integrates with clinical trial management systems to ensure participants attend visits prepared. This technology reduces no-shows and streamlines the recruitment process, enhancing patient experience and accelerating trial enrollment.

Climedo offers a web-based eClinical platform that facilitates the collection of high-quality clinical data through electronic Clinical Outcome Assessments (eCOA) and Real-World Data (RWD) for non-interventional studies. The platform enhances data quality and compliance while reducing time and costs associated with traditional paper-based data collection methods in clinical research.

The startup provides clinical trial and therapy services that enhance patient engagement and optimize trial processes for pharmaceutical companies. By improving the quality of patient data and fostering trust in trial partnerships, the company addresses inefficiencies in clinical research and patient recruitment.

Themison is a patient-centric platform that utilizes real-time engagement analytics and a mobile app to enhance communication and support throughout clinical trials. By simplifying complex medical information and personalizing patient experiences, the platform aims to reduce dropout rates and accelerate trial completion.

Ancora.ai is a digital platform that utilizes artificial intelligence to match patients with relevant clinical trials based on their medical profiles and preferences. This approach addresses the challenge of low patient enrollment in clinical studies, enhancing recruitment efficiency and accelerating the trial process.

CliniNote provides a platform that utilizes AI-driven tools to capture and structure high-quality clinical real-world data in real time, ensuring interoperability and data consistency. This addresses the critical need for reliable clinical data to enhance research, drug development, and patient care without increasing the workload for healthcare professionals.

This clinical trials platform provides a comprehensive suite of tools for pharmaceutical, biotech, and CRO clients, streamlining workflows from consent management and televisit scheduling to patient data collection. It enhances participant engagement and offers operational dashboards for study control, leveraging distributed computing for global accessibility.

Cytocast provides a digital twin platform for simulating molecular interactions within human cells to predict drug efficacy and side effects. By integrating multi-omics and patient-specific data, the platform accelerates drug discovery and development by enabling _in silico_ testing and personalized medicine insights.

The startup develops an EHR data analysis platform that utilizes machine learning algorithms to identify symptomatic patients based on specific phenotypes for clinical trials. This technology enhances the recruitment process for drug testing, enabling researchers to efficiently target and examine new treatments on suitable candidates.

Provides a HIPAA-compliant platform that integrates with electronic health records (EHR) to automate patient pre-screening and recruitment for clinical trials. By leveraging AI-driven patient matching and site management partnerships, it reduces enrollment delays, increases trial accessibility for rural and community-based providers, and enables real-time monitoring of recruitment progress for sponsors.

Partex NV is a digital pharma platform that utilizes AI and blockchain technology to create an equitable patient data exchange and enhance decision-making in drug development. The platform addresses inefficiencies in the drug development process by accelerating the identification of overlooked pharmaceutical assets and improving access to valuable healthcare data.

Aparito's Atom5™ eCOA platform digitizes clinical trials by capturing high-frequency data through video assessments, wearable devices, and electronic patient-reported outcomes (ePROs). This technology enables clinical teams to obtain real-time insights from real-world data, enhancing the efficiency and accuracy of trial monitoring.

EvidentIQ provides an integrated cloud platform for clinical data management, featuring electronic data capture (EDC), clinical trial management systems (CTMS), and electronic trial master files (eTMF) to streamline decentralized clinical trials. The platform enhances patient engagement and data reliability, addressing inefficiencies in clinical research processes and improving the accuracy of patient-centered outcomes.

PatLynk connects patients with suitable clinical trials through advanced data analytics and a patient-centric platform, enhancing trial accessibility and efficiency. The startup addresses the challenge of patient recruitment in clinical research, facilitating faster and more effective trial participation.

GeneHub is a clinical trials accelerator that connects patients with drug developers to enhance access to relevant medications. The platform streamlines patient recruitment and data collection, addressing the inefficiencies in clinical trial processes that delay drug availability.

The startup offers a mental health treatment platform that utilizes clinical outcome measurement tools to enhance therapy sessions and track patient progress. By providing healthcare professionals with actionable insights, the platform aims to improve treatment quality and facilitate meaningful clinical conversations.

RareCan operates a clinical trial matching platform specifically for patients with rare and less common cancers, utilizing proprietary algorithms to analyze patient data against over 600 active trials in the UK. This service addresses the challenge of limited treatment options for rare cancer patients by providing tailored trial recommendations and expert support throughout the enrollment process.

This startup develops medical information applications that facilitate access to clinical trial data by organizing and categorizing information on patient recruitment centers and hospitals. By providing direct contact details, the platform enhances physician efficiency in matching patients to clinical trials, reducing delays in trial participation.

The startup provides an AI assistant that automates administrative tasks for doctors and nurses involved in clinical trials, enhancing the efficiency of life sciences research. By minimizing manual workload, the solution accelerates trial processes and improves team satisfaction, ultimately leading to better patient outcomes.